Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
Itha
Srivenu
S
Sharma
Abhinav
A
Bhatt
Ganesh
G
D000890:Anti-Infective Agents / Q000627:therapeutic use; D001201:Ascites / Q000150:complications*; D001424:Bacterial Infections / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D020117:Cisapride / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D008103:Liver Cirrhosis / Q000150:complications*; D009643:Norfloxacin / Q000627:therapeutic use*; D010538:Peritonitis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D005765:Gastrointestinal Agents; D009643:Norfloxacin; D020117:Cisapride